|
Stories from the dialysis comunity across the globe.
|
|
Amgen Announces Top-Line Results Of Trial To Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) In CKD ... (Medical News Today) |
 |
 |
|
Amgen (Nasdaq: AMGN) announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment read more |
|
|
|
|
|
<< Start < Prev 3671 3672 3673 3674 3675 3676 3677 3678 3679 3680 Next > End >>
|
|
Page 3676 of 4210 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
